TARDBP and amyotrophic lateral sclerosis: In 95–97% of ALS patients, TDP-43, the protein product of TARDBP, is found mislocalized from the nucleus into cytoplasmic aggregates (Masrori and Van Damme, 2020; Shatunov and Al-Chalabi, 2021).